Sihto H - Search Results

1

Risk factors for gastrointestinal stromal tumor recurrence in patients treated with adjuvant imatinib.

Joensuu H, Eriksson M, Hall KS, Hartmann JT, Pink D, Schütte J, Ramadori G, Hohenberger P, Duyster J, Al-Batran SE, Schlemmer M, Bauer S, Wardelmann E, Sarlomo-Rikala M, Nilsson B, Sihto H, Ballman KV, Leinonen M, DeMatteo RP, Reichardt P. Joensuu H, et al. Among authors: sihto h. Cancer. 2014 Aug 1;120(15):2325-33. doi: 10.1002/cncr.28669. Epub 2014 Apr 15. Cancer. 2014. PMID: 24737415 Free PMC article. Clinical Trial.

2

KIT and platelet-derived growth factor receptor alpha tyrosine kinase gene mutations and KIT amplifications in human solid tumors.

Sihto H, Sarlomo-Rikala M, Tynninen O, Tanner M, Andersson LC, Franssila K, Nupponen NN, Joensuu H. Sihto H, et al. J Clin Oncol. 2005 Jan 1;23(1):49-57. doi: 10.1200/JCO.2005.02.093. Epub 2004 Nov 15. J Clin Oncol. 2005. PMID: 15545668

3

Genetic alterations and protein expression of KIT and PDGFRA in serous ovarian carcinoma.

Lassus H, Sihto H, Leminen A, Nordling S, Joensuu H, Nupponen NN, Butzow R. Lassus H, et al. Among authors: sihto h. Br J Cancer. 2004 Dec 13;91(12):2048-55. doi: 10.1038/sj.bjc.6602252. Br J Cancer. 2004. PMID: 15583695 Free PMC article.

4

Amplification of genes encoding KIT, PDGFRalpha and VEGFR2 receptor tyrosine kinases is frequent in glioblastoma multiforme.

Joensuu H, Puputti M, Sihto H, Tynninen O, Nupponen NN. Joensuu H, et al. Among authors: sihto h. J Pathol. 2005 Oct;207(2):224-31. doi: 10.1002/path.1823. J Pathol. 2005. PMID: 16021678

5

NF1-associated gastrointestinal stromal tumors have unique clinical, phenotypic, and genotypic characteristics.

Andersson J, Sihto H, Meis-Kindblom JM, Joensuu H, Nupponen N, Kindblom LG. Andersson J, et al. Among authors: sihto h. Am J Surg Pathol. 2005 Sep;29(9):1170-6. doi: 10.1097/01.pas.0000159775.77912.15. Am J Surg Pathol. 2005. PMID: 16096406

6

Gene amplification, mutation, and protein expression of EGFR and mutations of ERBB2 in serous ovarian carcinoma.

Lassus H, Sihto H, Leminen A, Joensuu H, Isola J, Nupponen NN, Butzow R. Lassus H, et al. Among authors: sihto h. J Mol Med (Berl). 2006 Aug;84(8):671-81. doi: 10.1007/s00109-006-0054-4. Epub 2006 Apr 11. J Mol Med (Berl). 2006. PMID: 16607561

7

Allelic imbalance of HER2 variant in sporadic breast and ovarian cancer.

Puputti M, Sihto H, Isola J, Butzow R, Joensuu H, Nupponen NN. Puputti M, et al. Among authors: sihto h. Cancer Genet Cytogenet. 2006 May;167(1):32-8. doi: 10.1016/j.cancergencyto.2004.09.023. Cancer Genet Cytogenet. 2006. PMID: 16682283

8

Gastrointestinal stromal tumors with KIT exon 11 deletions are associated with poor prognosis.

Andersson J, Bümming P, Meis-Kindblom JM, Sihto H, Nupponen N, Joensuu H, Odén A, Gustavsson B, Kindblom LG, Nilsson B. Andersson J, et al. Among authors: sihto h. Gastroenterology. 2006 May;130(6):1573-81. doi: 10.1053/j.gastro.2006.01.043. Gastroenterology. 2006. PMID: 16697720

9

Platelet-derived growth factor receptor family mutations in gastrointestinal stromal tumours.

Sihto H, Franssila K, Tanner M, Vasama-Nolvi C, Sarlomo-Rikala M, Nupponen NN, Joensuu H, Isola J. Sihto H, et al. Scand J Gastroenterol. 2006 Jul;41(7):805-11. doi: 10.1080/00365520500483207. Scand J Gastroenterol. 2006. PMID: 16785193

10

Amplification of KIT, PDGFRA, VEGFR2, and EGFR in gliomas.

Puputti M, Tynninen O, Sihto H, Blom T, Mäenpää H, Isola J, Paetau A, Joensuu H, Nupponen NN. Puputti M, et al. Among authors: sihto h. Mol Cancer Res. 2006 Dec;4(12):927-34. doi: 10.1158/1541-7786.MCR-06-0085. Mol Cancer Res. 2006. PMID: 17189383

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

84 results

Search Page